France· FR:65512856
MIRTAZAPINE ALMUS 15 mg, comprimé orodispersible
A mirtazapine product containing mirtazapine, registered in France by ALMUS FRANCE, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Mirtazapine is registered in 18 of 19 countries.
Countries holding a registration under ATC N06AX11 (mirtazapine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 11 of them publish a price we can compare per daily dose
Mirtazapine · ATC N06AX11
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mirtazapine costs, country by country.
Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.22 in France to $1.40 in Switzerland — a ×6.4 gap.
- France: $0.22 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Mirtazapine · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.40
- IT Italy$0.61
- FR France$0.22
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MIRTAZAPINE
- Manufacturer
- ALMUS FRANCE
- Country
- France (FR)
- ATC code
- N06AX11
- ATC class
- Mirtazapine
- Defined daily dose
- 30 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400939023410plaquette(s) thermoformée(s) papier polyester aluminium polyamide PVC de 30 comprimé(s)EUR 2.88
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
482 interactions on record for mirtazapine.
Graded by severity as the source publishes them — 50 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mirtazapine · interactions on record
482 records
- 50 severe
- 234 moderate
- 2 minor
- 162 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
34 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mirtazapine in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomMirtazapine 15mg orodispersible tabletsConsilient Health Ltd
- FinlandFinamedNucleus ehf
- SpainMIRTAZAPINA APOTEX 15 mg COMPRIMIDOS BUCODISPERSABLES EFGApotex Europe B.V.
- BelgiumMirtazapine AB 15 mgAurobindo
- PolandAuroMirta OROAurovitas Pharma Polska Sp. z o.o.
- United StatesMirtazapineSQUARE PHARMACEUTICALS LIMITED
- SwitzerlandMirtazapin Sandoz eco 15 mg, SchmelztablettenSandoz Pharmaceuticals AG
- IrelandMirap DisTab 15 mg orodispersible tabletsRowex Limited,
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Mirtabene, Mirtabene Ratiopharm Gmbh
- Belgium · Mirtazapine Ab, Mirtazapine Eg
- Bulgaria · Мирзатен, Мирзатен Q-Tab
- Cyprus · Mirtazapin Aurobindo, Remeron
- Czechia · Miranox, Mirtazapin +pharma
- Germany · Mirta, Mirta Tad
- Denmark · Combar, Mirtazapin "hexal"
- Estonia · Mirtastad, Mirtazapin Actavis
- Spain · Afloyan, Mirtazapina Almus
- Finland · Mirtazapin Actavis, Mirtazapin Grindeks
- United Kingdom (Northern Ireland) · Mirtazapine, Mirtazapine Accord Healthcare
- Greece · Anchopriv, Azapin
- Croatia · Calixta, Mirtazapin Genericon
- Hungary · Mirtadepi, Mirtastad
- Ireland · Mirap, Mirap Distab
- Iceland · Míron, Miron Smelt
- Italy · Mirtazapin Grindeks, Mirtazapina Almus
- Lithuania · Mirtazapin Actavis, Mirtazapin Grindeks
- Luxembourg · Mirtazapin Ratiopharm, Mirtazapine Eg
- Latvia · Mirtastad, Mirtazapine Grindeks
- Malta · Mirap, Mirap Distab
- Netherlands · Mirtazapine Amarox, Mirtazapine Aurobindo
- Norway · Mirtazapin Actavis, Mirtazapin Bluefish
- Poland · Auromirta Oro, Mirtagen
- Portugal · Mirtazapin Grindeks, Mirtazapina Almus
- Romania · Mirtazapin Arena, Mirtazapină Aurobindo
- Sweden · Mirtazapin Actavis, Mirtazapin Alternova
- Slovenia · Mirtazapin Grindeks, Mirtazapine Grindeks
- Slovakia · Mirzaten, Mirzaten Q-Tab
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9db20ea-f9b4-45a2-b5f5-49bac6a40292 GET /v1/drugs/a9db20ea-f9b4-45a2-b5f5-49bac6a40292?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65512856",
"date_amm": "2008-11-12",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MIRTAZAPINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé orodispersible",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about mirtazapine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.